First American Financial Corporation to Participate in KBW Virtual Title Insurance Day Conference
SANTA ANA, Calif.–(BUSINESS WIRE)–First American Financial Corporation (NYSE: FAF), a premier provider of title, settlement and risk solutions for real... Read more.
Delisting and Cancellation of Trading From the London Stock Exchange
NEW YORK–(BUSINESS WIRE)–Further to the announcement made on 27th October 2023, Marsh & McLennan Companies, Inc. (the “Company“) announces... Read more.
Oshkosh Defense to Produce Medium Equipment Trailers for U.S. Army
OSHKOSH, Wis.–(BUSINESS WIRE)–Oshkosh Defense announced today that the U.S. Army Contracting Command – Detroit Arsenal (ACC-DTA) awarded a production... Read more.
Grupo Supervielle Reports 3Q23 Results
Delivering improved profitability with ROE at 18.5% in 3Q23, and 12.9% in 9M23 BUENOS AIRES, Argentina–(BUSINESS WIRE)–Grupo Supervielle S.A. (NYSE:... Read more.
inTEST Corporation Announces Stock Repurchase Plan
MT. LAUREL, N.J.–(BUSINESS WIRE)–inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for... Read more.
JPMorgan Chase & Co. Declares Quarterly Coupon on Alerian MLP Index ETN
NEW YORK–(BUSINESS WIRE)–JPMorgan Chase & Co. announced today the quarterly coupon amount for the Alerian MLP Index ETN (NYSE Arca: AMJ). The table... Read more.
MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds
BOSTON–(BUSINESS WIRE)–MFS Investment Management® (MFS®) released today the distribution income sources for six of its closed-end funds for November... Read more.
Fifth Third Bancorp to Participate in the Goldman Sachs U.S. Financial Services Conference
CINCINNATI–(BUSINESS WIRE)–Fifth Third Bancorp (Nasdaq: FITB) will participate in the 2023 Goldman Sachs U.S. Financial Services Conference on December... Read more.
Fifth Third Bancorp to Participate in the Goldman Sachs U.S. Financial Services Conference
CINCINNATI–(BUSINESS WIRE)–Fifth Third Bancorp (Nasdaq: FITB) will participate in the 2023 Goldman Sachs U.S. Financial Services Conference on December... Read more.
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Additional Trial Required to Demonstrate Positive Effect on the Treatment of Ocular Symptoms in Dry Eye Disease Special Protocol Assessment Submitted on November... Read more.